SAMHSA Aligned · Reviewed 2026-05-12 · MHPAEA Parity Verified

Cigna MAT Coverage: Suboxone, Methadone, and Vivitrol Through Evernorth Behavioral Health

Coverage details, prior authorization, copays, network rules, appeal rights, and ASAM Level coverage for Cigna plans seeking Medication-Assisted Treatment (MAT).

(239) 496-8492 Free helpline · 24/7 confidential
Quick Verdict · ~30 sec read
Reviewed by RehabHive Editorial Team · Last updated 2026-05-12
Cigna covers all three FDA-approved MAT medications (buprenorphine, methadone, naltrexone) through its behavioral-health subsidiary Evernorth Behavioral Health under MHPAEA federal parity. Generic sublingual buprenorphine is tier-1 on Cigna’s commercial formulary and requires no prior auth at FDA-labeled outpatient doses on most plans. Methadone is dispensed only through SAMHSA-certified Opioid Treatment Programs under Evernorth OTP contracts. Cigna’s Substance Use Disorder Coach program offers free telephonic peer-recovery support alongside MAT. Member cost-share averages – per generic prescription and – per office visit on commercial plans.
SAMHSA & NIDA sourced ASAM Criteria 4ed View 6 sources

ASAM Levels Covered

Cigna aligns its coverage with the American Society of Addiction Medicine (ASAM) Criteria, the national standard for matching patients to the appropriate intensity of care.

ASAM Level Covered Coverage Notes
1.0 Outpatient Yes Office-based buprenorphine; oral naltrexone; Vivitrol — typically no prior auth on generics
2.1 Intensive Outpatient Yes Evernorth Behavioral Health concurrent review; 9+ hrs/week
2.5 Partial Hospitalization Yes MAT continuation; concurrent review every 5-7 days
3.1 Low-Intensity Residential Yes Sober living with MAT continuation
3.5 Medium-Intensity Residential Yes Standard residential with MAT integration; prior auth + concurrent review
3.7 Medically Monitored Withdrawal Yes 24-hour nursing supervision; methadone/buprenorphine induction
4.0 Medically Managed Inpatient Yes Hospital-based for complex withdrawal or co-occurring medical

Prior Authorization

Cigna prior authorization for MAT is administered by Evernorth Behavioral Health, Cigna’s behavioral-health subsidiary. Generic sublingual buprenorphine-naloxone (Suboxone film/tablet) is tier-1 on Cigna’s commercial formulary and requires no prior auth at FDA-labeled outpatient doses (up to 24mg/6mg daily). Brand Suboxone film, Sublocade extended-release injection, and Vivitrol require prior auth with documentation: OUD ICD-10 diagnosis (F11.20), prescriber DEA registration, treatment plan, and any prior medication history. Methadone is dispensed only through SAMHSA-certified OTPs under Cigna’s OTP network contracts, billed at the HCPCS H0020 weekly bundled rate. Initial prior auth turnaround through Evernorth: 24-72 hours non-urgent, 24 hours urgent. Cigna’s 2024 update streamlined OUD-related prior auth in response to MHPAEA enforcement.

Cost-Sharing

Cigna MAT cost-share varies by plan funding type and tier. On commercial Cigna PPO and HMO plans, generic buprenorphine runs – per 30-day tier-1 fill; brand Suboxone film – on tier-2 after step-therapy. Office visits: PCP / - specialist copay. ASAM Level 2.1 IOP applies 20-30% coinsurance after deductible. Vivitrol injection (J2315): member cost typically public function index()–0 after prior auth + manufacturer copay assistance. Cigna Medicare Advantage caps MAT generics at public function index()– copay in 2026. Cigna self-funded employer plans (administered by Cigna/Evernorth) may apply employer-specific cost-share. Marketplace Cigna Connect plans expose retail price until deductible — pre-deductible 30-day generic buprenorphine retail roughly –0.

In-Network vs Out-of-Network

Cigna’s behavioral-health network is managed by Evernorth Behavioral Health and includes approximately 175,000 in-network behavioral providers nationally. For office-based buprenorphine, prescriber network status drives cost-share. Cigna’s LocalPlus HMO has narrower local networks; Cigna OAP (Open Access Plus) offers broadest network. OTP network for methadone is narrower than office-based MAT network — confirm your specific OTP’s Cigna participation before starting. Cigna’s 2024 network expansion added 11,000 SUD-focused providers in response to MHPAEA enforcement gaps.

Step-Therapy & Fail-First

Cigna applies step-therapy to Sublocade and brand Suboxone film, requiring 30-60 day documented trial of generic buprenorphine-naloxone before approving the more expensive option. Vivitrol is rarely subject to step-therapy when prescriber documents the patient cannot use opioid agonists. Methadone has no step-therapy per SAMHSA TIP 63 first-line. Step-therapy exceptions: request with medical necessity documentation; Evernorth must respond within 72 hours non-urgent / 24 hours urgent. As of 2025, Cigna eliminated step-therapy on injectable Vivitrol after MHPAEA enforcement findings.

Federal Parity (MHPAEA) Protections

MHPAEA prohibits Cigna from imposing more restrictive financial or non-quantitative treatment limitations on MAT than on comparable medical-surgical benefits. The 2024 MHPAEA final rule requires Cigna to maintain Comparative Analysis demonstrating Evernorth Behavioral Health’s prior auth, fail-first, network composition, and concurrent review for MAT are comparable in stringency to limitations on equivalent medical care. Cigna paid .6 million in a 2023 DOL settlement for MHPAEA violations including stricter prior auth on SUD vs medical-surgical. File MHPAEA complaints at askebsa.dol.gov or your state insurance commissioner.

Real-World Example

A 37-year-old Cigna OAP member in Texas started office-based MAT for OUD in 2025. Initial visit: specialist copay. Generic buprenorphine-naloxone (16mg/4mg daily) tier-1: copay per 30-day fill. Cigna SUD Coach enrolled (free telephonic peer support, monthly check-ins). 12 weeks IOP at Evernorth-network facility: per session copay × 36 sessions = public function index(),440. Total first-year MAT out-of-pocket: public function index(),700 against ,500 deductible and ,500 OOP max. Cigna Coach program credited with member’s sustained 12-month abstinence reported in 2026 follow-up.

Composite example for educational purposes; not a guarantee of coverage. Verify your specific plan benefits.

Frequently Asked Questions

Does Cigna cover Suboxone?
Yes. Generic sublingual buprenorphine-naloxone (Suboxone film/tablet) is tier-1 on Cigna’s commercial formulary and requires no prior auth at FDA-labeled outpatient doses on most plans. Brand Suboxone film and Sublocade extended-release injection require prior auth via Evernorth Behavioral Health. Generic copay typically – per 30-day fill on tier-1.
What is Evernorth Behavioral Health?
Evernorth Behavioral Health is Cigna’s behavioral-health subsidiary (formerly Cigna Behavioral Health). It manages prior authorization, network credentialing, and care management for all Cigna mental health and SUD benefits. When you have a Cigna plan and need MAT, prior auth flows through Evernorth. Evernorth maintains approximately 175,000 in-network behavioral providers nationally.
Does Cigna cover methadone treatment?
Yes. Cigna covers methadone exclusively through SAMHSA-certified Opioid Treatment Programs (OTPs) under Evernorth Behavioral Health’s OTP network contracts. The OTP bills the HCPCS H0020 weekly bundled rate covering medication, dispensing, drug testing, and counseling. Member typically pays the outpatient mental health weekly copay, around – on commercial plans, public function index() on Medicaid.
What is the Cigna SUD Coach program?
The Cigna Substance Use Disorder Coach is a free telephonic peer-recovery support program available to all Cigna members in MAT or other SUD treatment. Coaches are certified peer specialists with lived recovery experience. Services include weekly or monthly check-ins, crisis support, treatment-plan reinforcement, and resource navigation. Sign up via Cigna member portal or by calling the number on your ID card.
Does Cigna cover Vivitrol?
Yes. Vivitrol (extended-release naltrexone, J-code J2315) is covered as a medical benefit on most Cigna plans, typically with prior authorization through Evernorth. Negotiated rate plus Vivitrol Co-Pay Savings Program from Alkermes typically brings member cost to public function index()–0 per monthly injection. Patient must be opioid-free 7-10 days before initial injection.
How fast does Cigna approve MAT prior auth?
Evernorth Behavioral Health processes non-urgent MAT prior auth within 72 hours and urgent (active withdrawal) within 24 hours, per federal rules. If your request is delayed beyond these windows without justification, file a complaint with your state insurance commissioner or DOL EBSA. Cigna 2024 internal SLAs target 48-hour non-urgent and 12-hour urgent turnaround.
Does Cigna require X-waiver for buprenorphine prescribers?
No. The Mainstreaming Addiction Treatment Act of 2023 eliminated the DEA X-waiver requirement nationally. Any prescriber with standard DEA registration can prescribe buprenorphine. Cigna and Evernorth cannot require X-waiver as a credentialing condition. If denied for "no X-waiver," appeal immediately citing the MAT Act.
Can I appeal a Cigna MAT denial?
Yes. Internal appeal within 180 days of denial; Cigna must respond within 30 days non-urgent or 72 hours urgent. If denied, external review by state-appointed Independent Review Organization within 4 months. External review reverses behavioral-health denials at approximately 40% in 2024 federal data. If denial reflects MHPAEA parity violation, file simultaneous DOL or state complaint.
Does Cigna Medicare Advantage cover MAT?
Yes. Cigna Medicare Advantage plans follow CMS rules: generic buprenorphine on Part D at public function index()– copay per 2026 opioid use disorder benefit. Methadone covered under Part B at SAMHSA-certified OTPs. Vivitrol under Part B as provider-administered injection. Most Cigna Medicare plans require no prior auth on outpatient generic MAT.
How do I find a Cigna MAT prescriber?
Use the Cigna provider directory at cigna.com or the Evernorth Behavioral Health provider finder. Filter for "Addiction Medicine" or "Substance Use Disorder" specialty. Verify the specific prescriber participates in your specific plan (HMO vs PPO vs LocalPlus differ). For methadone, confirm the SAMHSA-certified OTP holds a current Cigna network contract.

Sources & Citations

  1. 1
    Cigna Coverage Policy: Substance Use Disorder — Insurer policy
  2. 2
    Evernorth Behavioral Health Provider Directory — Insurer subsidiary
  3. 3
    SAMHSA TIP 63: Medications for Opioid Use Disorder — Federal clinical guideline
  4. 4
    ASAM National Practice Guideline for OUD — Professional society guideline
  5. 5
    MHPAEA Final Rule 2024 — Federal parity regulation
  6. 6
    NIDA Medications to Treat Opioid Addiction — NIH research summary
Free helpline · 24/7

Verify Your Cigna Coverage

Call the SAMHSA National Helpline 24/7 (free, confidential) or use our directory to find Cigna-network facilities offering Medication-Assisted Treatment (MAT).

SAMHSA 1-800-662-4357 All Cigna details →
Related Coverage

Compare Cigna with other coverage options

Cigna + Inpatient Residential Rehab
Coverage details, prior auth, copays
Cigna + Medical Detox
Coverage details, prior auth, copays
Cigna + Partial Hospitalization (PHP)
Coverage details, prior auth, copays
Cigna + Intensive Outpatient (IOP)
Coverage details, prior auth, copays
Cigna + Standard Outpatient
Coverage details, prior auth, copays
Aetna + Medication-Assisted Treatment (MAT)
Coverage details, prior auth, copays
BCBS + Medication-Assisted Treatment (MAT)
Coverage details, prior auth, copays
UnitedHealthcare + Medication-Assisted Treatment (MAT)
Coverage details, prior auth, copays
Medicare + Medication-Assisted Treatment (MAT)
Coverage details, prior auth, copays

Last reviewed: 2026-05-12 · RehabHive Editorial Team · Based on publicly available Cigna coverage policies, SAMHSA guidelines, and federal MHPAEA regulations.

This information is educational and does not constitute insurance advice. Verify your specific plan benefits directly with Cigna before making treatment decisions.